Most people with MGUS never get a more serious condition. MGUS can turn into multiple myeloma. It also can turn into another blood disease, either: Amyloidosis Waldenström’s macroglobulinemia ...

For decades, the diagnosis of multiple myeloma required evidence of end ... mg per 24 h and/or clonal BMPCs 10-60% Absence of MDEs or amyloidosis In 2018, an updated risk stratification model ...

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

Dr. Rahul Banerjee is a physician-researcher who specializes in multiple myeloma, a blood cancer caused by plasma cells that can cause bone and kidney damage. Dr. Banerjee also treats patients with AL ...

Dr. Kara Cicero is a hematologist-oncologist focused on global oncology and cancer disparities research to advance health equity, with specific clinical expertise in multiple myeloma, AL amyloidosis ...

Multiple myeloma is when the plasma cells grow out of control and become cancerous. It can sometimes be mistaken for other plasma cell disorders like: This staging classifies myeloma in three ...

Pharmac director of pharmaceuticals Geraldine MacGibbon said it understood the significant impact of multiple myeloma and AL amyloidosis, and was speaking with daratumumab supplier Janssen.

renal AL amyloidosis and LCDD. [20] It is not uncommon for patients with MM to have both Bence Jones proteinuria and some albuminuria. However, myeloma-associated albuminuria is generally mild ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved an indication extension of DARZALEX® (daratumumab) subcutaneous (SC) ...